TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

THE J MOLNER

Infectious DiseaseDermatology
Generics

THE J MOLNER is a generic drug manufacturer focused on Infectious Disease, Dermatology.

2004
Since
5
Drugs
-
Trials
34
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

CIPROFLOXACIN HYDROCHLORIDE 2025-12-17
Labeling
LIDOCAINE HYDROCHLORIDE 2025-10-02
Manufacturing (CMC)
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%
1 drugs
Dermatology 50%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology
COSETTE other
Dermatology, Infectious Disease
BAUSCH AND LOMB specialty
Infectious Disease, Dermatology